When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Hormone replacement therapy - Wikipedia

   en.wikipedia.org/wiki/Hormone_replacement_therapy

   Hormone replacement therapy (HRT), also known as menopausal hormone therapy or postmenopausal hormone therapy, is a form of hormone therapy used to treat symptoms associated with female menopause. [ 1 ] [ 2 ] Effects of menopause can include symptoms such as hot flashes , accelerated skin aging, vaginal dryness , decreased muscle mass , and ...

3. The #1 Treatment That Can Help Menopausal Skin - AOL

   www.aol.com/im-dermatologist-one-treatment-turn...

   However, as with taking any medicine, the hormones used in hormone replacement therapy can cause possible side effects. "For bioidentical hormone replacement therapy using pellets (which is what ...

4. What are the signs you need hormone replacement therapy ... - AOL

   www.aol.com/signs-hormone-replacement-therapy...

   Hormone replacement therapy could be a major key to unlocking health benefits for women going through menopause, according to new research.. A study published Aug. 29 in the journal JAMA Network ...

5. Short-term menopausal hormone therapy may not affect ... - AOL

   www.aol.com/lifestyle/short-term-menopausal...

   New research suggests that short-term hormone therapy for menopause symptoms does not have long-term cognitive effects, whether harmful or beneficial. Short-term menopausal hormone therapy may not ...

6. Estradiol acetate - Wikipedia

   en.wikipedia.org/wiki/Estradiol_acetate

   Side effects of estradiol acetate include breast tenderness, breast enlargement, nausea, headache, and fluid retention. [7] [5] [6] Estradiol acetate is an estrogen and hence is an agonist of the estrogen receptor, the biological target of estrogens like estradiol. [8] [9] It is an estrogen ester and a prodrug of estradiol in the body.

7. Side effects of cyproterone acetate - Wikipedia

   en.wikipedia.org/wiki/Side_effects_of_cyprotero...

   The Women's Health Initiative randomized controlled trials demonstrated a significantly increased risk of breast cancer with 0.625 mg/day conjugated estrogens and 2.5 mg/day medroxyprogesterone acetate (a progestin closely related to CPA) for menopausal hormone therapy relative to 0.625 mg/day conjugated estrogens alone and placebo in peri-and ...